Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 2 days, and 1 more · Every feed →

All 34Congress 0Executive branch 0Insiders 34
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

TVTX · sells only · $100K+ · 34 trades

Trades
34
Buys 0 · Sells 34
People
11
Stocks
1
Disclosed value
$67.1M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLElizabeth E Reed Chief Legal Officer and GCTVTX Travere Therapeutics, Inc.$1.4Mdisclosed Sep 17 · filed 2 days after the trade
  2. ▼ SELLPeter Heerma EVP, Chief Commercial OfficerTVTX Travere Therapeutics, Inc.$5.9Mdisclosed Sep 17 · filed 1 day after the trade
  3. ▼ SELLEric M Dube Chief Executive OfficerTVTX Travere Therapeutics, Inc.$3.9Mdisclosed Sep 17 · filed 2 days after the trade
  4. ▼ SELLChristopher R. Cline Chief Financial OfficerTVTX Travere Therapeutics, Inc.$1.7Mdisclosed Sep 17 · filed 2 days after the trade
  5. ▼ SELLPeter Heerma EVP, Chief Commercial OfficerTVTX Travere Therapeutics, Inc.$5Mdisclosed Sep 17 · filed 1 day after the trade
  6. ▼ SELLChristopher R. Cline Chief Financial OfficerTVTX Travere Therapeutics, Inc.$1.3Mdisclosed Sep 17 · filed 2 days after the trade
  7. ▼ SELLPeter Heerma EVP, Chief Commercial OfficerTVTX Travere Therapeutics, Inc.$539Kdisclosed Sep 17 · filed the same day
  8. ▼ SELLEric M Dube Chief Executive OfficerTVTX Travere Therapeutics, Inc.$442Kdisclosed Sep 17 · filed the same day
  9. ▼ SELLJula Inrig EVP, Head of R&D & CMOTVTX Travere Therapeutics, Inc.$102Kdisclosed Sep 17 · filed 2 days after the trade
  10. ▼ SELLWilliam E. Rote Chief Research OfficerTVTX Travere Therapeutics, Inc.$4Mdisclosed Sep 17 · filed 2 days after the trade
  11. ▼ SELLElizabeth E Reed Chief Legal Officer and GCTVTX Travere Therapeutics, Inc.$869Kdisclosed Sep 17 · filed 2 days after the trade
  12. ▼ SELLEric M Dube Chief Executive OfficerTVTX Travere Therapeutics, Inc.$1.8Mdisclosed Sep 17 · filed 2 days after the trade
  13. ▼ SELLEric M Dube Chief Executive OfficerTVTX Travere Therapeutics, Inc.$197Kdisclosed Sep 17 · filed 2 days after the trade
  14. ▼ SELLEric M Dube Chief Executive OfficerTVTX Travere Therapeutics, Inc.$6.1Mdisclosed Sep 17 · filed 1 day after the trade
  15. ▼ SELLPeter Heerma EVP, Chief Commercial OfficerTVTX Travere Therapeutics, Inc.$4.5Mdisclosed Sep 17 · filed 2 days after the trade
  16. ▼ SELLWilliam E. Rote Chief Research OfficerTVTX Travere Therapeutics, Inc.$4.1Mdisclosed Sep 17 · filed 1 day after the trade
  17. ▼ SELLPeter Heerma EVP, Chief Commercial OfficerTVTX Travere Therapeutics, Inc.$1.7Mdisclosed Sep 17 · filed 2 days after the trade
  18. ▼ SELLJula Inrig EVP, Head of R&D & CMOTVTX Travere Therapeutics, Inc.$1.1Mdisclosed Sep 17 · filed 2 days after the trade
  19. ▼ SELLEric M Dube Chief Executive OfficerTVTX Travere Therapeutics, Inc.$6.3Mdisclosed Sep 17 · filed 1 day after the trade
  20. ▼ SELLWilliam E. Rote Chief Research OfficerTVTX Travere Therapeutics, Inc.$1.8Mdisclosed Sep 17 · filed 2 days after the trade
  21. ▼ SELLEric M Dube Chief Executive OfficerTVTX Travere Therapeutics, Inc.$6.6Mdisclosed Sep 17 · filed the same day
  22. ▼ SELLSandra Calvin SVP, Chief Accounting OfficerTVTX Travere Therapeutics, Inc.$266Kdisclosed Sep 17 · filed 2 days after the trade
  23. ▼ SELLWilliam E. Rote Chief Research OfficerTVTX Travere Therapeutics, Inc.$3Mdisclosed Sep 17 · filed 1 day after the trade
  24. ▼ SELLChristopher R. Cline Chief Financial OfficerTVTX Travere Therapeutics, Inc.$121Kdisclosed Sep 17 · filed 2 days after the trade
  25. ▼ SELLWilliam E. Rote Chief Research OfficerTVTX Travere Therapeutics, Inc.$191Kdisclosed Sep 17 · filed 2 days after the trade